Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Mirova US LLC

Mirova US LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 377,745 shares of the medical equipment provider’s stock after purchasing an additional 7,933 shares during the quarter. Intuitive Surgical accounts for 2.1% of Mirova US LLC’s holdings, making the stock its 20th largest holding. Mirova US LLC owned about 0.11% of Intuitive Surgical worth $168,040,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of ISRG. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth approximately $26,000. Able Wealth Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Delos Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,655,048.26. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,552 shares of company stock worth $26,281,657. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 1.1 %

ISRG opened at $492.63 on Friday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $493.97. The business has a 50 day moving average price of $454.69 and a two-hundred day moving average price of $414.46. The company has a market cap of $175.06 billion, a PE ratio of 88.92, a P/E/G ratio of 5.43 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the business earned $1.18 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently commented on ISRG shares. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2nd. BTIG Research boosted their target price on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research note on Wednesday. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Finally, Barclays boosted their price objective on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.